Literature DB >> 12652157

Nitric oxide and cardiovascular protection.

Bodh I Jugdutt1.   

Abstract

Nitric oxide (NO) plays a critical role in ischemic heart disease and ischemia-reperfusion. There is an increasing body of evidence to support the role of NO in myocardial and vascular protection in disease. The finding that NO might act as a trigger of late ischemic preconditioning (IPC) might lead to the development of novel anti-ischemic therapy. The role of NO signaling in the cardioprotective effects of ACE inhibitors and angiotensin II type 1 receptor(AT(1)) receptor antagonists is an active area of study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12652157     DOI: 10.1023/a:1022190820131

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  88 in total

Review 1.  Nitric oxide: pathophysiological mechanisms.

Authors:  S S Gross; M S Wolin
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

Review 2.  The role of nitric oxide in the failing heart.

Authors:  W J Paulus
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

3.  Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

Authors:  Y H Liu; X P Yang; V G Sharov; O Nass; H N Sabbah; E Peterson; O A Carretero
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

4.  Effect of intravenous nitroglycerin on collateral blood flow and infarct size in the conscious dog.

Authors:  B I Jugdutt; L C Becker; G M Hutchins; B H Bulkley; P R Reid; C H Kallman
Journal:  Circulation       Date:  1981-01       Impact factor: 29.690

5.  The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning.

Authors:  R Bolli; S Manchikalapudi; X L Tang; H Takano; Y Qiu; Y Guo; Q Zhang; A K Jadoon
Journal:  Circ Res       Date:  1997-12       Impact factor: 17.367

6.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Impact of left ventricular unloading after late reperfusion of canine anterior myocardial infarction on remodeling and function using isosorbide-5-mononitrate.

Authors:  B I Jugdutt; M I Khan; S J Jugdutt; G E Blinston
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

8.  Angiotensin II type 2 receptor blockade amplifies the early signals of cardiac growth response to angiotensin II in hypertrophied hearts.

Authors:  J Bartunek; E O Weinberg; M Tajima; S Rohrbach; B H Lorell
Journal:  Circulation       Date:  1999 Jan 5-12       Impact factor: 29.690

Review 9.  Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases.

Authors:  H Matsubara
Journal:  Circ Res       Date:  1998 Dec 14-28       Impact factor: 17.367

10.  Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.

Authors:  Y Nio; H Matsubara; S Murasawa; M Kanasaki; M Inada
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

View more
  2 in total

1.  Emergent role of gasotransmitters in ischemia-reperfusion injury.

Authors:  Bridgette F Moody; John W Calvert
Journal:  Med Gas Res       Date:  2011-04-27

2.  Non-invasive technology that improves cardiac function after experimental myocardial infarction: Whole Body Periodic Acceleration (pGz).

Authors:  Arkady Uryash; Jorge Bassuk; Paul Kurlansky; Francisco Altamirano; Jose R Lopez; Jose A Adams
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.